These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1326342

  • 1. PA-III rat prostate adenocarcinoma cells (review).
    Koutsilieris M.
    In Vivo; 1992; 6(2):199-203. PubMed ID: 1326342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The expression of mRNA for glucocorticoid receptor gene and functional glucocorticoid receptors detected in PA-III rat prostate adenocarcinoma cells.
    Koutsilieris M, Grondin F, Lehoux JG.
    Anticancer Res; 1992; 12(3):899-904. PubMed ID: 1622147
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
    Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindan MV, Polychronakos C.
    Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
    [Abstract] [Full Text] [Related]

  • 6. Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved.
    Polychronakos C, Janthly U, Lehoux JG, Koutsilieris M.
    Prostate; 1991; 19(4):313-21. PubMed ID: 1661415
    [Abstract] [Full Text] [Related]

  • 7. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C, Teti A, Bianco P, Guerra F, Vicentini C, Tennina R, Villanova I, Sciortino G, Bologna M.
    Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
    [Abstract] [Full Text] [Related]

  • 8. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J, Stetter-Neel C, Cole D, Durham JP, Mawhinney MG.
    J Urol; 1997 Jul 01; 158(1):269-74. PubMed ID: 9186373
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 11. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 01; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
    Evans CP, Elfman F, Parangi S, Conn M, Cunha G, Shuman MA.
    Cancer Res; 1997 Aug 15; 57(16):3594-9. PubMed ID: 9270033
    [Abstract] [Full Text] [Related]

  • 16. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
    Goel HL, Breen M, Zhang J, Das I, Aznavoorian-Cheshire S, Greenberg NM, Elgavish A, Languino LR.
    Cancer Res; 2005 Aug 01; 65(15):6692-700. PubMed ID: 16061650
    [Abstract] [Full Text] [Related]

  • 17. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME, Deeble PD, Lakhani S, Parsons SJ.
    Cancer Res; 1999 Aug 01; 59(15):3821-30. PubMed ID: 10447001
    [Abstract] [Full Text] [Related]

  • 18. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats.
    Powolny AA, Wang S, Carlton PS, Hoot DR, Clinton SK.
    Mol Carcinog; 2008 Jun 01; 47(6):458-65. PubMed ID: 18058807
    [Abstract] [Full Text] [Related]

  • 19. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
    Hall CL, Tsan R, Mugnai G, Mazar A, Radinsky R, Pettaway CA.
    Prostate; 2004 May 01; 59(2):167-76. PubMed ID: 15042617
    [Abstract] [Full Text] [Related]

  • 20. Stromal-epithelial paracrine interactions in the neoplastic rat and human prostate.
    Djakiew D, Pflug B, Onoda M.
    Adv Exp Med Biol; 1993 May 01; 330():185-202. PubMed ID: 8368133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.